Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.73 USD | +3.06% | +2.28% | +1.97% |
05-09 | Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-26 | Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.97% | 474M | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.67% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- NKTX Stock
- News Nkarta, Inc.
- Nkarta Shares Double on Partnership With Lupus Therapeutics for Cell Therapy to Treat Lupus, FDA Application Approval